Literature DB >> 8218539

Serum erythropoietin levels in thalassemia intermedia.

F Dore1, S Bonfigli, E Gaviano, S Pardini, P Cianciulli, G Papa, M Longinotti.   

Abstract

Serum concentrations of erythropoietin (EPO) were determined by immunoassay in 45 patients with thalassemia intermedia (TI). The mean serum level of EPO was significantly higher in the thalassemic patients than in the controls, but transfused subjects had lower pretransfusional serum concentrations of EPO than untransfused ones. An inverse relationship between the serum values of EPO and total hemoglobin was observed only in the untransfused thalassemic patients. These data suggest that in TI, even a low transfusional regimen may cause a decrease in serum concentration of EPO, independent of the level of total Hb.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218539     DOI: 10.1007/bf01695865

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  7 in total

1.  Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.

Authors:  E A Rachmilewitz; A Goldfarb; G Dover
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

2.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

3.  Erythropoietin levels in heterozygous beta-thalassemia.

Authors:  M Vedovato; G Salvatorelli; C Vullo; M Taddei Masieri; G C Balboni
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

4.  Erythropoietin levels in heterozygous alpha-thalassemia.

Authors:  M Vedovato; G Salvatorelli; G C Balboni; M Taddei Masieri; B Dolcini; C Toffoli
Journal:  Acta Haematol       Date:  1986       Impact factor: 2.195

5.  Erythropoietin activity in the serum of beta thalassemic patients.

Authors:  D Manor; E Fibach; A Goldfarb; E A Rachmilewitz
Journal:  Scand J Haematol       Date:  1986-09

6.  Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia.

Authors:  M André; P Bergmann; A Ferster; M Toppet; P Fondu
Journal:  Nouv Rev Fr Hematol       Date:  1991

7.  Sickle cell anemia patients have low erythropoietin levels for their degree of anemia.

Authors:  J B Sherwood; E Goldwasser; R Chilcote; L D Carmichael; R L Nagel
Journal:  Blood       Date:  1986-01       Impact factor: 22.113

  7 in total
  4 in total

1.  Erythropoiesis is not equally suppressed in transfused males and females with β-thalassemia major: are there clinical implications?

Authors:  Greg Hapgood; Timothy Walsh; Ronit Cukierman; Eldho Paul; Ken Cheng; Donald K Bowden
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941

2.  Low doses of rHuEPO administered to adult patients with thalassemia intermedia.

Authors:  F Dore; E Gaviano; S Bonfigli; S Pardini; P Pistidda; L Guiso; M Longinotti
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

Review 3.  The transfusion management of beta thalassemia in the United States.

Authors:  Ashutosh Lal; Trisha Wong; Siobán Keel; Monica Pagano; Jong Chung; Aditi Kamdar; Latha Rao; Alan Ikeda; Geetha Puthenveetil; Sanjay Shah; Jennifer Yu; Elliott Vichinsky
Journal:  Transfusion       Date:  2021-08-28       Impact factor: 3.337

4.  The antioxidant effect of erythropoietin on thalassemic blood cells.

Authors:  Johnny Amer; Mutaz Dana; Eitan Fibach
Journal:  Anemia       Date:  2010-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.